Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. smartscope-x

Smartscope-X SIGNED

Affordable, accessible and automatic screening solution for diabetic retinopathy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 Smartscope-X project word cloud

Explore the words cloud of the Smartscope-X project. It provides you a very rough idea of what is the project "Smartscope-X" about.

ambition    primary    grading    hence    care    visual    trained    billion    frequent    automatic    vision    clinical    annually    regular    hours    service    people    images    diabetes    prevent    finnish    storage    eye    422m    graded    becomes    retinopathy    validations    threatening    investment    solution    cloud    precision    642m    impairment    safety    fundus    screenings    detect    approvals    prevention    time    screening    piloting    2040    combines    diagnosed    adults    handheld    endocrinology    optomed    efficient    ophthalmologist    health    stage    algorithm    oy    commercialise    limited    combination    affordable    ltd    complication    global    globally    data    grader    accessible    clinics    camera    disease    smartscope    validate    customers    consists    preventable    blindness    diabetic    resource    automated    aged    components    projected    retinal    commercialisation    diabetics    dr   

Project "Smartscope-X" data sheet

The following table provides information about the project.

Coordinator		 OPTOMED OY 

Organization address
address: YRTTIPELLONTIE 1
city: OULU
postcode: 90230
website: www.optomed.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Finland [FI]
 Project website https://www.optomed.com/single-post/2017/08/23/Optomed-receives-funding-from-Horizon-2020-EU-Program
 Total cost 2˙817˙050 €
 EC max contribution 1˙971˙935 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2020-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OPTOMED OY FI (OULU) coordinator 1˙971˙935.00

Map

 Project objective

Diabetes is a growing global health concern, affecting 422M people today and the number is projected to rise to 642M by 2040. Over 30 % of diabetics develop a vision-threatening complication called diabetic retinopathy (DR), which is the most frequent cause of preventable blindness in working-aged adults. DR is diagnosed from retinal images traditionally graded by an ophthalmologist. Regular eye screenings are the only effective way to detect disease at early stage to prevent visual impairment or blindness. Hence, globally more than 1 billion screenings would be needed annually. Time, cost and resource efficient screening methods are needed to reach all diabetics. Finnish Optomed Oy (Ltd.) combines the precision of their handheld fundus camera with an automatic DR grading to establish Smartscope-X solution. Smartscope-X consists of three main components: a low-cost handheld fundus camera, an automated screening algorithm and cloud service for fundus images. With this unique combination, Optomed’s vision is to bring affordable, accessible and automatic DR screening available for all diabetics. In this project, the key ambition is to validate and commercialise Smartscope-X solution. The project has four objectives: (1) DR algorithm is integrated into Optomed fundus camera and Optomed Cloud service is developed, (2) clinical validations are conducted, (3) piloting and commercialisation of the Smartscope-X, with necessary approvals, (4) to establish a data safety and storage system. Smartscope-X will have a significant impact on visual impairment and blindness prevention in Europe and globally. Today, significant equipment investment and an experienced grader or ophthalmologist are needed. Hence, DR screening availability is limited. Smartscope-X user can be trained to use the solution in 1-2 hours. Screening with Smartscope-X will cost 10 % of current. Therefore, DR screening becomes available to new customers such as endocrinology clinics and even primary care.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SMARTSCOPE-X" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SMARTSCOPE-X" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More